CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 25 enrolled
Drug / intervention
Treatment for recurrent oropharyngeal cancer (curative/ palliative)other
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04952922
NCT04952922N/ACompleted
CompareCT.gov

Changes to Function and Quality of Life and Patient Experience for Patients Undergoing Treatments for Recurrent Oropharyngeal Cancer

Royal Marsden NHS Foundation Trust·observational·Posted Jul 7, 2021·Updated Aug 8, 2025

In Brief

An observational study evaluating Treatment for recurrent oropharyngeal cancer (curative/ palliative) for Recurrent Oropharynx Carcinoma. Completed, enrolled 25 participants across 1 site.

Detailed Summary

The purpose of this research project is to measure changes in communication, swallowing and quality of life and individual patient priorities which may happen over time in patients with a diagnosis of recurrent head and neck cancer, specifically recurrent cancer (cancer which has returned after previous treatment) of the back of the throat, the tonsils and/or the base of tongue (recurrent oropharyngeal cancer) and what it is like for patients and their significant others to experience these changes over time.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsRecurrent Oropharynx Carcinoma
CountriesUnited Kingdom
CollaboratorsImperial College London

Timeline

N/ACompletedFinished
20222023202420252026
First PostedJul 7, 2021
Enrollment StartOct 27, 2021
Primary CompletionMay 13, 2024
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 5.0 years ago

Interventions

Treatment for recurrent oropharyngeal cancer (curative/ palliative)other

Open salvage surgery, transoral robotic surgery, palliative chemotherapy, immunotherapy.